Santo J. Costa - 20 Jun 2024 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Reporting relationship: Director
Issuer ticker: AQST
Reported as of: 20 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Jun 2024, 13:50:10 UTC
Prior SEC filing: 16 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Lori Braender, as Attorney-In-Fact

Key filing fact

Santo J. Costa filed Form 4 for Aquestive Therapeutics, Inc. (AQST) on 21 Jun 2024.

Key facts

This page summarizes Santo J. Costa's Form 4 filing for Aquestive Therapeutics, Inc. (AQST).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 21 Jun 2024, 13:50.

Change

Previous filing in this sequence was filed on 16 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AQST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 17,327
Date: 20 Jun 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AQST transaction Derivative

Stock Option (Right to Purchase)

Award

Transaction value: $0
Shares: +38,000
Change %
Price: $0.000000
Shares after: 38,000
Date: 20 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,000
Exercise price: $2.50
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Costa's continuous service with the Issuer from the grant date through the applicable vesting date.